The efficacy and safety of once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitusXianying Wang,Xuejing Li,Suhui Qie,Yingying Zheng,Yang Liu,Guoqiang LiuMedicine(2018)引用 7|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要